Literature DB >> 3458216

Localization of the human pim oncogene (PIM) to a region of chromosome 6 involved in translocations in acute leukemias.

L Nagarajan, E Louie, Y Tsujimoto, A ar-Rushdi, K Huebner, C M Croce.   

Abstract

The human homolog, hpim, of the murine pim-1 gene, which is activated in murine T-cell lymphomas by insertion of retrovirus proviral genomes in the pim-1 region, has been molecularly cloned; the cloned probe has been used to map the hpim locus to human chromosome region 6p21 by somatic cell hybrid analysis and chromosomal in situ hybridization. The hpim gene is expressed as a 3.2-kilobase mRNA in various human cell lines of hematopoietic lineage, most dramatically in the K562 erythroleukemia cell line, which contains a cytogenetically demonstrable rearrangement in the 6p21 region. A characteristic chromosome anomaly, a reciprocal translocation t(6;9)(p21;q33), has been described in myeloid leukemias and could involve the hpim gene.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3458216      PMCID: PMC323337          DOI: 10.1073/pnas.83.8.2556

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  41 in total

1.  Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome.

Authors:  C B Lozzio; B B Lozzio
Journal:  Blood       Date:  1975-03       Impact factor: 22.113

2.  Continuous growth and differentiation of human myeloid leukaemic cells in suspension culture.

Authors:  S J Collins; R C Gallo; R E Gallagher
Journal:  Nature       Date:  1977-11-24       Impact factor: 49.962

3.  Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose.

Authors:  P S Thomas
Journal:  Proc Natl Acad Sci U S A       Date:  1980-09       Impact factor: 11.205

4.  Evolution of karyotypes in acute nonlymphocytic leukemia.

Authors:  J R Testa; U Mintz; J D Rowley; J W Vardiman; H M Golomb
Journal:  Cancer Res       Date:  1979-09       Impact factor: 12.701

5.  Characterization of the continuous, differentiating myeloid cell line (HL-60) from a patient with acute promyelocytic leukemia.

Authors:  R Gallagher; S Collins; J Trujillo; K McCredie; M Ahearn; S Tsai; R Metzgar; G Aulakh; R Ting; F Ruscetti; R Gallo
Journal:  Blood       Date:  1979-09       Impact factor: 22.113

6.  Transcriptional control of the expression of mouse globin genes in myeloma x erythroleukemia cell hybrids.

Authors:  A Ar-Rushdi; K B Tan; C M Croce
Journal:  Somatic Cell Genet       Date:  1982-03

7.  Chromosomal banding patterns in acute nonlymphocytic leukemia.

Authors:  J D Rowley; D Potter
Journal:  Blood       Date:  1976-05       Impact factor: 22.113

8.  Assignment of the gene for glyoxalase I to region p21 leads to pter of human chromosome 6.

Authors:  P McBreen; E Engel; C M Croce
Journal:  Cytogenet Cell Genet       Date:  1977

9.  Expression of HLA-A, but not of HLA-B, in mouse-human somatic cell hybrids carrying the region p21 leads to pter of human chromosome 6.

Authors:  C M Zmijewski; E Engel; C M Croce
Journal:  Eur J Immunol       Date:  1978-08       Impact factor: 5.532

10.  Characterization of EBV-genome negative "null" and "T" cell lines derived from children with acute lymphoblastic leukemia and leukemic transformed non-Hodgkin lymphoma.

Authors:  U Schneider; H U Schwenk; G Bornkamm
Journal:  Int J Cancer       Date:  1977-05-15       Impact factor: 7.396

View more
  29 in total

1.  Regional localization of human ecto-5' nucleotidase to chromosome 6q14-q21.

Authors:  J M Boyle; Y Hey; K H Grzeschik; L Thompson; E Munro; M Fox
Journal:  Hum Genet       Date:  1989-09       Impact factor: 4.132

Review 2.  Comparative map for mice and humans.

Authors:  J H Nadeau; M T Davisson; D P Doolittle; P Grant; A L Hillyard; M R Kosowsky; T H Roderick
Journal:  Mamm Genome       Date:  1992       Impact factor: 2.957

3.  Structural alteration in the MYB protooncogene and deletion within the gene encoding alpha-type protein kinase C in human melanoma cell lines.

Authors:  A J Linnenbach; K Huebner; E P Reddy; M Herlyn; A H Parmiter; P C Nowell; H Koprowski
Journal:  Proc Natl Acad Sci U S A       Date:  1988-01       Impact factor: 11.205

4.  Characterization of the testes-specific pim-1 transcript in rat.

Authors:  D Wingett; R Reeves; N S Magnuson
Journal:  Nucleic Acids Res       Date:  1992-06-25       Impact factor: 16.971

Review 5.  Comparative map for mice and humans.

Authors:  J H Nadeau; M T Davisson; D P Doolittle; P Grant; A L Hillyard; M Kosowsky; T H Roderick
Journal:  Mamm Genome       Date:  1991       Impact factor: 2.957

6.  The (6;9) chromosome translocation, associated with a specific subtype of acute nonlymphocytic leukemia, leads to aberrant transcription of a target gene on 9q34.

Authors:  M von Lindern; A Poustka; H Lerach; G Grosveld
Journal:  Mol Cell Biol       Date:  1990-08       Impact factor: 4.272

Review 7.  Myocardial AKT: the omnipresent nexus.

Authors:  Mark A Sussman; Mirko Völkers; Kimberlee Fischer; Brandi Bailey; Christopher T Cottage; Shabana Din; Natalie Gude; Daniele Avitabile; Roberto Alvarez; Balaji Sundararaman; Pearl Quijada; Matt Mason; Mathias H Konstandin; Amy Malhowski; Zhaokang Cheng; Mohsin Khan; Michael McGregor
Journal:  Physiol Rev       Date:  2011-07       Impact factor: 37.312

8.  The gene encoding human vimentin is located on the short arm of chromosome 10.

Authors:  S Ferrari; L A Cannizzaro; R Battini; K Huebner; R Baserga
Journal:  Am J Hum Genet       Date:  1987-10       Impact factor: 11.025

9.  The human c-ros gene (ROS) is located at chromosome region 6q16----6q22.

Authors:  L Nagarajan; E Louie; Y Tsujimoto; P C Balduzzi; K Huebner; C M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

10.  Transcriptional upregulation of both egl-1 BH3-only and ced-3 caspase is required for the death of the male-specific CEM neurons.

Authors:  R Nehme; P Grote; T Tomasi; S Löser; H Holzkamp; R Schnabel; B Conradt
Journal:  Cell Death Differ       Date:  2010-02-12       Impact factor: 15.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.